Maxim Group Begins Coverage on Abpro (NASDAQ:ABP)

Maxim Group started coverage on shares of Abpro (NASDAQ:ABP) in a report issued on Monday, Marketbeat Ratings reports. The brokerage issued a buy rating and a $4.00 target price on the stock.

Abpro Price Performance

ABP opened at $0.66 on Monday. The firm has a fifty day moving average price of $1.39. Abpro has a fifty-two week low of $0.65 and a fifty-two week high of $13.00.

Institutional Trading of Abpro

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Jane Street Group LLC acquired a new stake in Abpro in the 4th quarter valued at $37,000. Geode Capital Management LLC acquired a new stake in shares of Abpro in the fourth quarter valued at about $53,000. LMR Partners LLP acquired a new stake in shares of Abpro in the fourth quarter valued at about $112,000. AQR Arbitrage LLC acquired a new position in shares of Abpro during the 4th quarter worth about $157,000. Finally, Atlas Merchant Capital LLC purchased a new position in Abpro in the 4th quarter valued at about $157,000. 23.30% of the stock is currently owned by hedge funds and other institutional investors.

About Abpro

Abpro Holdings Inc is a biotechnology company. The company’s mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc, formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.